Tiempo real estimado
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
6,385 USD | -2,37 % | +2,40 % | +13,10 % |
Resumen de negocios
Número de empleados: 145
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Targeted Protein Degradation
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 31 | 100,0 % | 21 | 100,0 % | -33,25 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Kendra Adams
DFI | Director of Finance/CFO | 48 | 20/11/20 |
Chief Tech/Sci/R&D Officer | - | 01/01/21 | |
Stewart Fisher
CTO | Chief Tech/Sci/R&D Officer | 57 | 01/05/16 |
Leonard Reyno
CTO | Chief Tech/Sci/R&D Officer | 61 | 10/07/23 |
Courtney Solberg
IRC | Investor Relations Contact | - | - |
Mark Mossler
AUD | Comptroller/Controller/Auditor | 51 | 01/06/23 |
Scott Boyle
PRN | Corporate Officer/Principal | 46 | 01/01/22 |
Adrian Bignami
PRN | Corporate Officer/Principal | - | 01/04/21 |
Jolie Siegel
LAW | General Counsel | 47 | 01/06/20 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Bruce Downey
CHM | Chairman | 76 | 01/12/15 |
Glenn Dubin
BRD | Director/Board Member | 67 | 12/03/21 |
Bihua Chen
PRN | Corporate Officer/Principal | 55 | 01/12/15 |
Donna Grogan
BRD | Director/Board Member | 67 | 29/07/22 |
Owen Hughes
BRD | Director/Board Member | 49 | 20/11 |
Kenneth Anderson
FOU | Founder | 72 | 01/10/15 |
Andrew Hirsch
CEO | Chief Executive Officer | 53 | 14/09/20 |
Malcolm Salter
BRD | Director/Board Member | 84 | 01/12/15 |
Utpal Koppikar
BRD | Director/Board Member | 53 | 16/03/22 |
Laura Bessen
BRD | Director/Board Member | 61 | 29/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 68 600 669 | 60 834 824 ( 88,68 %) | 0 | 88,68 % |
Información de la empresa
Sector
Revisiones del BPA
Varia. 1 de ene. | Capi. | |
---|---|---|
+13,10 % | 450 M | |
+21,40 % | 42,68 mil M | |
-2,56 % | 42,4 mil M | |
+45,32 % | 40,04 mil M | |
-6,20 % | 28,31 mil M | |
+8,08 % | 24,94 mil M | |
-19,92 % | 18,96 mil M | |
+30,08 % | 12,3 mil M | |
-2,59 % | 11,95 mil M | |
-2,73 % | 11,55 mil M |
- Bolsa de valores
- Acciones
- Acción CCCC
- Empresa C4 Therapeutics, Inc.